<http://schema.org/description>
"FDA Grants Genentech&amp;#039;s Obinutuzumab (GA101) Priority Review for Previously Untreated Chronic Lymphocytic Leukemia (CLL)   -- Announcement Follows FDA Breakthrough Therapy Designation for"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2013/07/03/fda-grants-genentechs-obinutuzumab-ga101-priority-/20645767/>